CSPC Pharmaceutical Group...

OTC: CSPCY · Real-Time Price · USD
5.56
0.15 (2.77%)
At close: Aug 15, 2025, 3:58 PM
5.41
-2.70%
After-hours: Aug 13, 2025, 08:00 PM EDT

CSPC Pharmaceutical Cash Flow Statement

Financials in CNY. Fiscal year is January - December.
Fiscal Year Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
Period Ending Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021
Net Income
3.02B 2.9B 3.1B 3.08B 3.06B 3.08B 3.67B
Depreciation & Amortization
631.23M 583.39M 554.06M 556.73M 495.45M 525.44M 515.51M
Stock-Based Compensation
118.18M 125.09M n/a n/a n/a n/a n/a
Other Working Capital
n/a -1.11B n/a n/a n/a n/a n/a
Other Non-Cash Items
-2.34B 2.9B -1.04B -243.31M 2.06B 1.58B 274.96M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
n/a -3.66B n/a 786.38M n/a -1.68B n/a
Operating Cash Flow
1.42B 2.85B 1.51B 3.07B 4.62B 2.45B 3.43B
Capital Expenditures
-648.89M -890.22M -1.07B -1.65B -999.84M -1.33B -794.39M
Cash Acquisitions
n/a -15.86M 458.46M -28.12M -246.01M 75.75M 210.62M
Purchase of Investments
n/a -400.74M -4.16B -1.52B -5.7B -1.93B -4.61B
Sales Maturities Of Investments
n/a 586.68M 6.14B 2.49B 856.83M 4.3B 3B
Other Investing Acitivies
-1.48B 647.66M -222.19M 41.19M -0.85 44.87M -29.21M
Investing Cash Flow
-2.13B -242.56M 1.14B -670.52M -6.09B 1.16B -2.23B
Debt Repayment
-85.92M n/a -81.99M n/a 320.58M n/a -194.43M
Common Stock Repurchased
-353M -243.81M -209.36M 1.07M -14.2M -318.94M n/a
Dividend Paid
-1.53B -1.52B -1.26B -985.47M -1.05B -970.18M -1.08B
Other Financial Acitivies
-291.07M 268.68M 55.14M 2.95M -33.19M -74.18M -17.4M
Financial Cash Flow
-2.29B -1.25B -1.48B -1.07B -792.45M -1.37B -1.29B
Net Cash Flow
7.49B 1.56B -251.17M 822.82M -624.22M 1.64B 1.07B
Free Cash Flow
775.86M 1.96B 437.76M 1.41B 3.62B 1.12B 2.64B